Bolt Biotherapeutics (BOLT) Accumulated Depreciation & Amortization (2019 - 2025)
Historic Accumulated Depreciation & Amortization for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $7.1 million.
- Bolt Biotherapeutics' Accumulated Depreciation & Amortization rose 408.64% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 408.64%. This contributed to the annual value of $7.3 million for FY2024, which is 2652.99% up from last year.
- According to the latest figures from Q3 2025, Bolt Biotherapeutics' Accumulated Depreciation & Amortization is $7.1 million, which was up 408.64% from $6.8 million recorded in Q2 2025.
- Over the past 5 years, Bolt Biotherapeutics' Accumulated Depreciation & Amortization peaked at $7.3 million during Q4 2024, and registered a low of $1.5 million during Q1 2021.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $4.8 million (2023), whereas its average is $4.6 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 8119.45% in 2021, then soared by 260.95% in 2025.
- Bolt Biotherapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $2.2 million in 2021, then surged by 74.39% to $3.9 million in 2022, then surged by 46.92% to $5.8 million in 2023, then grew by 26.53% to $7.3 million in 2024, then decreased by 2.01% to $7.1 million in 2025.
- Its last three reported values are $7.1 million in Q3 2025, $6.8 million for Q2 2025, and $6.5 million during Q1 2025.